2014
DOI: 10.1016/j.neuint.2014.02.006
|View full text |Cite
|
Sign up to set email alerts
|

NADPH oxidase inhibition improves neurological outcome in experimental traumatic brain injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
34
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(36 citation statements)
references
References 27 publications
2
34
0
Order By: Relevance
“…TBI rapidly up-regulates NOX2 enzyme subunits in injured neurons and astrocytes during the acute phase after injury, followed by high NOX2 expression in amoeboid-like microgila/macrophages during the sub-acute and chronic periods (Dohi et al, 2010; Kumar et al, 2015; Loane et al, 2014). NOX2 inhibition by pharmacological or genetic means is neuroprotective (Dohi et al, 2010; Loane et al, 2013; Lu et al, 2014; Zhang et al, 2012), in part, by modulating secondary neuroinflammation and microglial activation. Previously, it has been shown that NOX2 deficiency resulted in reduced O 2− and peroxynitrite metabolites in the injured cortex; effects that were associated with reduced neuronal cell death and microglial activation (Dohi et al, 2010).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…TBI rapidly up-regulates NOX2 enzyme subunits in injured neurons and astrocytes during the acute phase after injury, followed by high NOX2 expression in amoeboid-like microgila/macrophages during the sub-acute and chronic periods (Dohi et al, 2010; Kumar et al, 2015; Loane et al, 2014). NOX2 inhibition by pharmacological or genetic means is neuroprotective (Dohi et al, 2010; Loane et al, 2013; Lu et al, 2014; Zhang et al, 2012), in part, by modulating secondary neuroinflammation and microglial activation. Previously, it has been shown that NOX2 deficiency resulted in reduced O 2− and peroxynitrite metabolites in the injured cortex; effects that were associated with reduced neuronal cell death and microglial activation (Dohi et al, 2010).…”
Section: Resultsmentioning
confidence: 99%
“…In injured cortex NOX2 is highly up-regulated in microglia/macrophages that co-express M1-like, or mixed M1-/M2-like activation markers, but not with single M2-like activation markers (Kumar et al, 2015). Increasingly, NOX2 is being recognized as an important therapeutic target for CNS injury (von Leden et al, 2016), and pharmacological or genetic intervention studies demonstrate that NOX2 inhibition after TBI is neuroprotective, mediated, in part, by targeting secondary neuroinflammation and microglial activation (Dohi et al, 2010; Loane et al, 2013; Lu et al, 2014; Zhang et al, 2012). …”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, combination therapies that inhibit both ER stress and oxidative stress might be a potentially better therapeutic strategy for preventing post-stroke and post-TBI secondary brain damage. Many antioxidant drugs like Edaravone and apocynin were shown to curtail ischemic and traumatic brain damage effectively (152156). …”
Section: Therapeutic Opportunities For Neuroprotection By Modulatimentioning
confidence: 99%
“…entry has been shown to play a critical role in the activation of NADPH oxidase and the subsequent production of superoxide in neutrophils (Brechard and Tschirhart 2008). Recently, mounting studies demonstrated that ROS generated by over-activated NADPH oxidase contributes significantly to oxidative stress and neuronal damage in CNS (Brennan et al 2009;Ansari and Scheff 2011;Hill et al 2014), and genetic or pharmacological modulation of NADPH oxidase has been demonstrated to considerably attenuate cerebral oxidative injury (Behrens et al 2007;Cairns et al 2012;Lu et al 2014). With the growing research on NADPH oxidase, its role in pathophysiological dysfunction of neural cells has attracted high attentions.…”
Section: Introductionmentioning
confidence: 99%